Nothing (healthy subject)
Conditions
Interventions
Longvida 2000mg/day, 4weeks
Placebo, 4weeks
Sponsors
ORTHOMEDICO, Inc.
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Healthy Japanese males and females 2. BMI>=18.5 and <25 kg/m2 3. Subjects who are judged as appropriate for the study by the principal investigator
Exclusion criteria
Exclusion criteria: 1. Subjects who have at least one previous medical history of malignant tumor, heart failure or myocardial infarction 2. Subjects who are patient or have history of cardiac arrhythmia, hepatic disorder, renal disorder, cerebrovascular disorder, rheumatism, diabetes mellitus, dyslipidemia, hypertension or other chronic diseases 3. Subjects who have undergone gastrointestinal tract surgery; except appendectomy 4. Subjects who are currently taking medicines (include herbal medicines) and/or supplements 5. Subjects who are allergic to medicines or the test material of this trial 6. Subjects who are or are possibly pregnant, or are lactating 7. Subjects who participate in other clinical trials in the past 3 months 8. Subjects who work time is irregular 9. Subjects who have been determined ineligible by principal investigator for other reasons
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| physical examination Hematologic test blood biochemical test urine analysis Doctor's questions adverse events | — |
Secondary
| Measure | Time frame |
|---|---|
| Questionnaires | — |
Countries
Japan
Contacts
Public ContactSatomi Iwata
Omnica Co.,Ltd Research and development Dept.
Outcome results
None listed